The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

CYLOSERINE AS AN ANTIDEPRESSANT AGENT

Published Online:https://doi.org/10.1176/ajp.115.11.1025

Cycloserine appears to be a psychopharmacological agent in that 1. It reverses depressions to normal or hyperactive mood and at the same time causes subtle changes in behavior; 2. It may aggravate mental disorders; and 3. It seems to potentiate Marsilid. Cycloserine may become a valuable tool in psychopharmacological research and may also find therapeutic use in depressions, provided the initial dose does not exceed 500 mg. a day and potentially psychotic patients receive more than average supervision.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.